Cargando…

Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain

AIM: We describe the effectiveness and safety of the interferon-free regimen ombitasvir/paritaprevir/ritonavir plus dasabuvir with or without ribavirin (OBV/PTV/r ± DSV ± RBV) in a nationwide representative sample of the hepatitis C virus (HCV) monoinfected and human immunodeficiency virus-1/hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Manuel Sousa, José, Vergara, Mercedes, Pulido, Federico, Sánchez Antolín, Gloria, Hijona, Lander, Carnicer, Fernando, Rincón, Diego, Salmerón, Javier, Mateos-Muñoz, Beatriz, Jou, Antoni, Polo-Lorduy, Benjamín, Rubín, Ángel, Escarda, Ana, Aguilar, Patricia, Aldámiz-Echevarría, Teresa, García-Buey, Luisa, Carrión, José A., Hernández-Guerra, Manuel, Chimeno-Hernández, Sonia, Espinosa, Nuria, Morillas, Rosa Mª, Andrade, Raúl J., Delgado, Manuel, Gallego, Adolfo, Magaz, Marta, Moreno-Planas, José María, Estébanez, Ángel, Rico, Mikel, Menéndez, Fernando, Sampedro, Blanca, Morano, Luís, Izquierdo, Sonia, Zozaya, José Manuel, Rodríguez, Manuel, Morán-Sánchez, Senador, Lorente, Sara, Martín-Granizo, Ignacio, Von-Wichmann, Miguel Ángel, Delgado, Marcial, Manzanares, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850697/
https://www.ncbi.nlm.nih.gov/pubmed/31714950
http://dx.doi.org/10.1371/journal.pone.0225061